Reuters Market Eye - Shares in AstraZeneca Pharma India surge as much as 7.6 percent on Tuesday after the company says its board approved a proposal from promoter AstraZeneca Pharmaceuticals AB, Sweden to delist the company from India.
Shares in AstraZeneca are up nearly 4 percent at 1.09 p.m. The stock hit a 52-week high of 1,286 rupees on March 4, since the company first announced the delisting proposal, and has gained 30.4 percent so far this month.
(Reporting by Indulal PM)